Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christoph Engel

Showing results (201-210 of 376) with videos related to

Pageof 38
Sort By:
International Journal of Cancer|July 9, 2005
Novel strategy for optimal sequential application of clinical criteria, immunohistochemistry and microsatellite analysis in the diagnosis of hereditary nonpolyposis colorectal cancerChristoph Engel, Jochen Forberg, Elke Holinski-Feder, et al.
Familial Cancer|March 16, 2011
Missense variants in hMLH1 identified in patients from the German HNPCC consortium and functional studiesKarin Hardt, Sven Boris Heick, Beate Betz, et al.
Life Science Alliance|October 22, 2022
The human RNA polymerase I structure reveals an HMG-like docking domain specific to metazoansJulia L Daiß, Michael Pilsl, Kristina Straub, et al.
JCO Precision Oncology|June 12, 2026
Constitutional <i>BRCA1</i> Promoter Methylation in Patients With Ovarian Cancer: Results of the Observational AGO-TR1 StudyMohamad Kayali, Eric Hahnen, Alexander Burges, et al.
Pilot and Feasibility Studies|December 30, 2016
Lifestyle intervention in BRCA1/2 mutation carriers: study protocol for a prospective, randomized, controlled clinical feasibility trial (LIBRE-1 study)Marion Kiechle, Christoph Engel, Anika Berling, et al.
Scientific Reports|May 13, 2026
Endothelial dysfunction and metabolic biomarkers in post-COVID-19 syndromeMartin Oestreich, Maria Schmidt, Julia Dittrich, et al.
Journal of Medical Genetics|April 9, 2013
Evaluating the performance of the breast cancer genetic risk models BOADICEA, IBIS, BRCAPRO and Claus for predicting BRCA1/2 mutation carrier probabilities: a study based on 7352 families from the German Hereditary Breast and Ovarian Cancer ConsortiumChristine Fischer, Karoline Kuchenbäcker, Christoph Engel, et al.
BMC Gastroenterology|October 6, 2010
Polymorphisms of genes coding for ghrelin and its receptor in relation to colorectal cancer risk: a two-step gene-wide case-control studyDaniele Campa, Barbara Pardini, Alessio Naccarati, et al.
Brain Communications|December 8, 2025
Retinal nerve fibre layer thickness is associated with attention and predicts risk states of dementiaMatthias L Schroeter, Johanna Girbardt, Tobias Luck, et al.
Gut|May 24, 2015
Activating ERBB2/HER2 mutations indicate susceptibility to pan-HER inhibitors in Lynch and Lynch-like colorectal cancerMichael Kloth, Vanessa Ruesseler, Christoph Engel, et al.
Pageof 38

Showing results (201-210 of 376) with videos related to

Sort By:
Pageof 38
International Journal of Cancer|July 9, 2005
Novel strategy for optimal sequential application of clinical criteria, immunohistochemistry and microsatellite analysis in the diagnosis of hereditary nonpolyposis colorectal cancerChristoph Engel, Jochen Forberg, Elke Holinski-Feder, et al.
Familial Cancer|March 16, 2011
Missense variants in hMLH1 identified in patients from the German HNPCC consortium and functional studiesKarin Hardt, Sven Boris Heick, Beate Betz, et al.
Life Science Alliance|October 22, 2022
The human RNA polymerase I structure reveals an HMG-like docking domain specific to metazoansJulia L Daiß, Michael Pilsl, Kristina Straub, et al.
JCO Precision Oncology|June 12, 2026
Constitutional <i>BRCA1</i> Promoter Methylation in Patients With Ovarian Cancer: Results of the Observational AGO-TR1 StudyMohamad Kayali, Eric Hahnen, Alexander Burges, et al.
Pilot and Feasibility Studies|December 30, 2016
Lifestyle intervention in BRCA1/2 mutation carriers: study protocol for a prospective, randomized, controlled clinical feasibility trial (LIBRE-1 study)Marion Kiechle, Christoph Engel, Anika Berling, et al.
Scientific Reports|May 13, 2026
Endothelial dysfunction and metabolic biomarkers in post-COVID-19 syndromeMartin Oestreich, Maria Schmidt, Julia Dittrich, et al.
Journal of Medical Genetics|April 9, 2013
Evaluating the performance of the breast cancer genetic risk models BOADICEA, IBIS, BRCAPRO and Claus for predicting BRCA1/2 mutation carrier probabilities: a study based on 7352 families from the German Hereditary Breast and Ovarian Cancer ConsortiumChristine Fischer, Karoline Kuchenbäcker, Christoph Engel, et al.
BMC Gastroenterology|October 6, 2010
Polymorphisms of genes coding for ghrelin and its receptor in relation to colorectal cancer risk: a two-step gene-wide case-control studyDaniele Campa, Barbara Pardini, Alessio Naccarati, et al.
Brain Communications|December 8, 2025
Retinal nerve fibre layer thickness is associated with attention and predicts risk states of dementiaMatthias L Schroeter, Johanna Girbardt, Tobias Luck, et al.
Gut|May 24, 2015
Activating ERBB2/HER2 mutations indicate susceptibility to pan-HER inhibitors in Lynch and Lynch-like colorectal cancerMichael Kloth, Vanessa Ruesseler, Christoph Engel, et al.
Pageof 38